← Back to Clinical Trials
Recruiting NCT05628389

NCT05628389 Phone Enabled Implementation of Cessation Support

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05628389
Status Recruiting
Phase
Sponsor University of Florida
Condition Smoking Cessation
Study Type INTERVENTIONAL
Enrollment 1,500 participants
Start Date 2024-03-06
Primary Completion 2027-08-30

Trial Parameters

Condition Smoking Cessation
Sponsor University of Florida
Study Type INTERVENTIONAL
Phase N/A
Enrollment 1,500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-03-06
Completion 2027-08-30
Interventions
Educational materialsPhone counselingNicotine Replacement Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The tobacco use burden in Lebanon is exceptionally high: 35% of adults are current cigarette smokers and 39% are current waterpipe smokers. Although the World Health Organization endorses evidence-based interventions for population-level tobacco dependence treatment, recommended treatments are not integrated as a routine part of primary care in Lebanon, as is the case in other low-resource settings. The objective of this proposal is to evaluate the comparative effectiveness of promising multi-component interventions for implementing evidence-based cessation treatment in Lebanon's national system of primary health care centers.

Eligibility Criteria

Inclusion Criteria: * Age 18+ * A current daily cigarette smoker and/or a regular waterpipe smoker (smokes at least 1-2 times/week). * Not pregnant * Reachable by phone * Interested in quitting * Lives in Greater Beirut Area Exclusion Criteria: * Patients who use other tobacco products including vape exclusively. * Any patient below 18 years old. * Cigarette smokers who do not smoke on daily basis. * Waterpipe smokers who smoke less than once/weekly

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology